-
effectivehealthcare.ahrq.gov/products/ptsd-repository-update/protocol
September 21, 2021 - exp Amphetamines/
(amphetamine or armodafanil or atomoxetine or dexmethylphenidate or dextroamphetamine
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd4-final-protocol.pdf
October 01, 2022 - trimipramine or
venlafaxine or vilazodone or vortioxetine).ti,ab. or exp Antidepressive Agents/
14. exp Amphetamines
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pharma-nonpharma-protocol.pdf
September 01, 2021 - sertraline or trazadone or trimipramine or
venlafaxine or vilazodone or vortioxetine).ti,ab.
24. exp Amphetamines
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol-2021_0.pdf
January 01, 2021 - sertraline or trazadone or trimipramine or
venlafaxine or vilazodone or vortioxetine).ti,ab.
24. exp Amphetamines
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
November 01, 2021 - Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents - Systematic Review Protocol
Evidence-based Practice Center Systematic Review Protocol
Project Title: ADHD Diagnosis and Treatment in Children and Adolescents
I. Background and Objectives for the Systematic Review
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-5-protocol-update-2023.pdf
January 01, 2023 - sertraline or trazadone or trimipramine or venlafaxine or vilazodone or vortioxetine).ti,ab.
24 exp Amphetamines
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol.pdf
July 10, 2018 - sertraline or trazadone or trimipramine or venlafaxine or vilazodone or vortioxetine).ti,ab.
24. exp Amphetamines
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-protocol.pdf
July 10, 2018 - sertraline or trazadone or trimipramine or venlafaxine or vilazodone or vortioxetine).ti,ab.
24. exp Amphetamines
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-executive-summary.pdf
March 01, 2024 - Executive Summary: ADHD Diagnosis and Treatment in Children and Adolescents
Comparative Effectiveness Review
Number 267
ADHD Diagnosis and Treatment in
Children and Adolescents
Executive Summary
Main Points
Diagnosis
• Multiple approaches showed promising diagnostic performance (e.g., usin…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_clinician.pdf
May 01, 2016 - . (���)
The FDA lists the following warnings:
�� CNS stimulants (amphetamines and methylphenidate-containing
-
effectivehealthcare.ahrq.gov/products/binge-eating/clinician
May 24, 2016 - evidence low]
FDA Medication Warnings
The FDA lists the following warnings:
CNS stimulants (amphetamines
-
effectivehealthcare.ahrq.gov/health-topics/drugs-and-young-people
January 17, 2012 - Strategies To Improve Cardiovascular Risk Factors in People With Serious Mental Illness: A Comparative Effectiveness Review
Research Protocol
Archived
January 17, 2012
Strategies for Improving the Lives of Women Aged 40 and Above Living with HIV/AIDS
Research Protocol
Archived
Marc…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-203-adhd-disposition-comments.pdf
January 01, 2018 - Disposition of Comments Report for CER 203 ADHD
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title:
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and
Adolescents
Draft review available for public comment from October 17, 2016, to November 14, …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psychiatric-readmissions_research-protocol.pdf
December 31, 2014 - psychiatric-readmissions-protocols-140904
Evidence-based Practice Center
Technical Brief Protocol
Project Title: Management Strategies to Reduce Psychiatric Readmi…
-
effectivehealthcare.ahrq.gov/products/psychiatric-readmissions/research-protocol
September 04, 2014 - Current Page Topic Timeline Nov. 23, 2010 Topic Suggestion Sep. 4, 2014 Research Protocol May. 21, 2015 Technical Brief Oct. 9, 2015 Disposition of Comments Report Management Strategies to Reduce Psychiatric Readmissions
Research Protocol Archived September 4, 2014 Download Main Document PDF 521.8 KB
…
-
effectivehealthcare.ahrq.gov/products/autism-adolescents/research-protocol
March 29, 2011 - inhibitors (citalopram/Celexa, escitalopram/Lexapro, fluoxetine/Prozac)
Psychostimulants (methylphenidate, amphetamines
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-adolescents_research-protocol.pdf
March 29, 2011 - (citalopram/Celexa, escitalopram/Lexapro, fluoxetine/Prozac)
- Psychostimulants (methylphenidate, amphetamines
-
effectivehealthcare.ahrq.gov/products/depression-treatment-ssri/research-protocol
June 15, 2010 - Current Page Topic Timeline Mar. 17, 2008 Topic Suggestion Jun. 15, 2010 Research Protocol Apr. 26, 2012 Systematic Review Jul. 3, 2013 Surveillance Report Depression Treatment after Unsatisfactory Response to SSRIs when used as First-line Therapy
Research Protocol Archived June 15, 2010 Download Main Document PDF…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol_0_0.pdf
November 04, 2021 - Maternal Morbidity and Mortality
Evidence-based Practice Center Systematic Review Protocol
Project Title: Maternal Morbidity and Mortality
I. Background
Maternal morbidity describes any short- or long-term health problem resulting from
pregnancy and childbirth,1 and maternal mortality refers …
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol-amendment.pdf
February 02, 2022 - Maternal Morbidity and Mortality
Evidence-based Practice Center Systematic Review Protocol
Project Title: Maternal Morbidity and Mortality
Initial Publication Date: December 9, 2021
Amendment Date: February 2, 2022
(Amendments Details–see Section VII)
I. Background
Maternal morbidity descr…